Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Dabigatran and Diclofenac Interaction Study
NCT02171507Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2006
- Primary completion
- Jul 2006
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dabigatran in thromboembolism (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve of dabigatran in plasma at steady state over one dosing interval, Maximum concentration of dabigatran in plasma at steady state and 6 more. Started May 2006; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02171507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171507.